Newsroom

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Dow Jones Internet UCITS ETF 21.04.2026 FDNU IE00BG0SSC32 1,175,002.00 USD 42,736,362.35 36.371  ...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust SMID Rising Dividend Achievers UCITS ETF 21.04.2026 SDVY.LN IE0001R850E1 14,429,007.00 USD 364,481,137.03   25.260  ...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Growth Strength UCITS ETF 21.04.2026 FTGS.LN IE000YZLMXT9   25,002.00 USD    571,862.96   22.873  ...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest U.S. Equity Moderate Buffer UCITS ETF - February 21.04.2026 GFEB.LN IE000X8M8M80  700,002.00 USD  26,699,871.11   38.143  ...

PISCATAWAY, N.J.--(BUSINESS WIRE)--Kashiv BioSciences, LLC (“Kashiv”), today announced that it has entered into a definitive agreement to be acquired by Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX) (“Amneal”). The transaction is subject to approval by Amneal shareholders, receipt of regulatory approvals and satisfaction of customary closing conditions and is expected to close in the second half of 2026. This acquisition combines Kashiv’s extensive expertise in the development and manufacturing o...

SANTA CRUZ, Calif.--(BUSINESS WIRE)--Joby Aviation, Inc. (NYSE:JOBY), a company developing electric air taxis for commercial passenger service, today announced that it expects to release its first quarter 2026 financial results after market close on Tuesday, May 5, 2026, and to host a webcast at 5:00 pm ET on the same day. The webcast will be publicly available in the Upcoming Events section of the company website, www.jobyaviation.com. If unable to attend the webcast, to listen by phone, pleas...

AUSTIN, Texas--(BUSINESS WIRE)--Oncology Ventures announced the close of its oversubscribed $62 million Fund II, nearly double the size of its $32 million Fund I and surpassing its $50 million target. The Fund is anchored by Texas Oncology, the largest physician-led oncology-focused practice in America, alongside renewed backing from the most influential institutions in cancer care. "1,700 people die of cancer every day in the U.S.," said Ben Freeberg, Founder and Managing Partner. "Research sh...

SAN CARLOS, Calif.--(BUSINESS WIRE)--BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, will report its first quarter 2026 financial results on Wednesday, May 6, 2026 before the financial markets open. Following the release of the financials, the Company will host a live webcast with management at 8:00 a.m. ET. The live webcast of this event can be accessed from the investors section of the Company’s website at https://ir.beonemedicines.com.To ensure a time...

WAKEFIELD, Mass.--(BUSINESS WIRE)--The Mojaloop Foundation today announced the appointment of Jean Bosco Iyacu as Chief Executive Officer, effective June 1, 2026. He succeeds Paula Hunter, who will retire. She will transition out of the Executive Director role during the leadership handover. Based in Kigali, Rwanda, Jean Bosco brings more than 15 years of experience in inclusive financial systems, digital finance and Digital Public Infrastructure (DPI) to enable the achievement of Sustainable D...

VANCOUVER, British Columbia--(BUSINESS WIRE)--Rewrite Capital Advisors Acquires ESOP Builders, Becoming Canada’s Most Comprehensive Employee Ownership Advisory Practice...